Patents by Inventor Thomas Simmet

Thomas Simmet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BOSWELLIC ACID EXTRACTION
    Publication number: 20200345801
    Abstract: The invention is directed to an improved method of extracting boswellic acid from Boswellia gum resin and the use of extracted boswellic acid in the manufacture of a pharmaceutical composition for treatment of an illness or disease in a patient in need thereof.
    Type: Application
    Filed: April 30, 2020
    Publication date: November 5, 2020
    Inventors: Luay Rashan, Sidgi Syed Anwer Abdo Hasson, Thomas Simmet, Mohammed Said Amur Al Balushi, Ali Abdullah Hasan Al-Jabri
  • Harpagoside-enriched extract from harpagophytum procumbens and processes for producing same
    Patent number: 6280737
    Abstract: The disclosure relates to extracts from Harpagophytum procumbens with a high harpagoside content, to processes for producing them, such extracts containing no components capable of stimulating the synthesis of thromboxane B2 and cysteinylleucotrienes, and to pharmaceutical compositions containing such extracts.
    Type: Grant
    Filed: February 22, 1999
    Date of Patent: August 28, 2001
    Assignee: Dr. Willmar Schwabe GmbH & Co.
    Inventors: Karl-Heinz Stumpf, Hermann Jaggy, Rainer Oschmann, Egon Koch, Thomas Simmet
  • Use of boswellic acid for treating brain tumors
    Patent number: 6174876
    Abstract: The present invention relates to the use of pure boswellic acid, a physiologically acceptable salt, a derivative, a salt of said derivative or a vegetable preparation containing boswellic acid for the preparation of a pharmaceutical composition for the treatment of brain tumours.
    Type: Grant
    Filed: July 2, 1999
    Date of Patent: January 16, 2001
    Assignee: Thomas Simmet
    Inventors: Thomas Simmet, Hermann P. T. Ammon
  • Use of boswellic acid for treating brain tumors
    Patent number: 5919821
    Abstract: The present invention relates to the use of pure boswellic acid, a physiologically acceptable salt, a derivative, a salt of said derivative or a vegetable preparation containing boswellic acid for the preparation of a pharmaceutical composition for the treatment of brain tumours.
    Type: Grant
    Filed: June 10, 1997
    Date of Patent: July 6, 1999
    Assignee: Thomas Simmet
    Inventors: Thomas Simmet, Hermann P. T. Ammon